Stephanie Resnik is an associate in the firm’s Washington, DC office, where she is a member of the Food, Drug, and Device Practice Group. She advises pharmaceutical, medical device, biotechnology, food, and tobacco companies on a variety of regulatory and compliance issues, including labeling, advertising, facility registration, CGMP compliance, and reporting requirements.
Ms. Resnik has experience counseling clients on interactions with federal and state regulatory agencies, including the Food and Drug Administration (FDA), the U.S. Department of Agriculture (USDA), the Federal Trade Commission (FTC), and state Boards of Pharmacy, as well as interactions with the Better Business Bureaus' (BBB) National Advertising Division (NAD). She has extensive experience working with state regulators and navigating complex state laws and regulations to determine the appropriate licenses or permits required to operate in such states.
Ms. Resnik regularly assists clients with preparing public comments for agency rulemakings and guidance documents. She also routinely provides regulatory advice and due diligence to support the corporate transactions of the firm’s life sciences practice.